gliclazide has been researched along with Seizures in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gopal-Kothandapani, JS | 1 |
| Wright, KP | 1 |
| Sithambaram, S | 1 |
| Natarajan, A | 1 |
1 other study available for gliclazide and Seizures
| Article | Year |
|---|---|
Dilemma of diagnosing sulphonylurea overdose in children: deliberations and considerations before reaching a diagnosis.
Topics: Adolescent; Blood Glucose; Diagnosis, Differential; Drug Overdose; Emergency Service, Hospital; Fema | 2017 |